Research Innovations

AI-Driven Vascular Access Lifecycle 360

RRI is developing an Al-based system that is designed to monitor the entire lifecycle of vascular access for dialysis patients. By integrating clinical data, imaging, sound data, and treatment parameters, the platform aims to predict complications earlier, potentially enabling proactive clinical intervention. This approach aims to reduce catheter dependence and improve long-term patient outcomes.

Biosignal Monitoring During Dialysis

RRI researchers pioneered the analysis of high-frequency biosignal data during dialysis treatments. By studying signals such as oxygen saturation, hematocrit, and hemodynamic changes, the team is researching patterns associated with complications like intradialytic hypotension, as well as outcomes in patients with AKI. These insights may support the development of smarter, more adaptive dialysis therapies.

Large-Scale Data Platforms and Advanced Modeling in Kidney Care

Building on the success of the MONitoring Dialysis Outcomes initiative (MONDO), RRI expanded its large-scale data infrastructure through initiatives such as ApolloDialDB™. These platforms integrate electronic health records, dialysis treatment data, and clinical outcomes into unified research environments, creating one of the most comprehensive multimodal data ecosystems in nephrology. This foundation enables advanced artificial intelligence approaches, including reinforcement learning models, to address complex clinical challenges such as bone and mineral metabolism. By continuously learning from patient data, these models have the potential to support more personalized treatment strategies and improve long-term outcomes.

Large Language Models in Kidney Care

RRI is exploring the use of large language models to support clinicians, patients, and care teams. These tools can assist with nutrition guidance, patient education, clinical documentation, and therapy optimization. By integrating language models with structured clinical data, RRI aims to create intelligent assistants for kidney care.

Intradialytic Hypotension Prediction

Intradialytic hypotension remains one of the most common complications of dialysis therapy. RRI has developed machine learning models designed to predict hypotensive events during treatment using real-time patient data and biosignals. These predictive tools may enable clinicians to intervene earlier and improve treatment stability.

Advanced Benchmarking and Mortality Prediction

RRI has developed sophisticated benchmarking tools that analyze large dialysis datasets to predict patient outcomes and identify opportunities to improve care delivery. These models combine machine learning with longitudinal clinical data and have led to new intellectual property and patented innovations. The tools aim to enable health systems to continuously learn from real-world practice.

Real-World Evidence for Hemodiafiltration

RRI has generated influential real-world evidence supporting the clinical benefits of hemodiafiltration. Using large international datasets and advanced statistical approaches, researchers evaluate the impact of HDF on survival, cardiovascular health, and treatment quality. These findings help guide clinical guidelines and global adoption of next-generation dialysis therapies.

Reinforcement Learning for Bone and Mineral Metabolism

Managing bone and mineral metabolism in dialysis patients is complex and highly individualized. Together with academic partners, RRI researchers are exploring reinforcement learning approaches that continuously learn from patient data to optimize treatment strategies. These models may help clinicians personalize therapy and improve long-term outcomes.

Virtual Clinical Trials and Patient Avatars

RRI’s computational medicine program uses mathematical models to simulate clinical trials using “virtual patient avatars.” These models replicate human physiology and allow researchers to test treatment strategies before real-world studies begin. Virtual trials have the potential to accelerate innovation while reducing cost and risk.

Expanding Home Dialysis Through Data and Evidence

RRI researchers study the clinical, operational, and behavioral factors that influence the adoption of home dialysis therapies. By analyzing real-world patient data and care pathways, the institute helps identify strategies that improve access to home-based treatment. These insights support global efforts to expand patient choice and independence.

© 2026 Renal Research Institute. All Rights reserved. The Renal Research Institute and RRI Logos are trademarks of Fresenius Medical Care Holdings, Inc. or its affiliated companies. All other trademarks are the property of their respective owners.